• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【药物名称】Tipranavir, PNU-140690E(diNa salt), PNU-140690, U-140690

【化学名称】N-[3-[1(R)-[4-Hydroxy-2-oxo-6(R)-(2-phenylethyl)-6-propyl-5,6-dihydro-2H-pyran-3-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide

【CA登记号】174484-41-4, 191150-83-1 (diNa salt)

【 分 子 式 】C31H33F3N2O5S

【 分 子 量 】602.67826

【开发单位】Pfizer (Originator), Boehringer Ingelheim (Licensee)

【药理作用】AIDS Medicines, Anti-HIV Agents, ANTIINFECTIVE THERAPY, HIV Protease Inhibitors

合成路线1

The condensation of 4(R)-phenyloxazolidin-2-one (I) with 2(E)-pentenoyl chloride (II) by means of BuLi in THF gives 3-[2(E)-pentenoyl]-3(R)-phenyloxazolidin-2-one (III), which is treated with 3-[bis(trimethylsilyl)amino]phenylmagnesium bromide (IV) and CuBr in DMSO/THF regioselectively yielding the addition product (V). Elimination of the silyl groups of (VII) in mild acidic conditions and treatment of the resulting amine with benzyl bromide affords the dibenzylated amine derivative (VI), which is regioselectively acylated with 2-methoxy-2-methyl-1,3-dioxolane (V) and TiCl4 in dichloromethane under basic conditions giving the dione (VIII). The condensation of (VIII) with 1-phenyl-3-hexanone (IX) by means of Ti(OBu)Cl3 in dichloromethane as before yields the hydroxy-dione (X), which is cyclized by means of potassium tert-butoxide in THF to afford the dihydropyrone (XI). The debenzylation of (XI) by hydrogenation with H2 over Pd/C in methanol/ethyl acetate gives the free amine (XII), which is finally sulfonated with 5-(trifluoromethyl)pyridine-2-sulfonyl chloride (XIII) in pyridine/dichloromethane

1 Graul, J.; Wroblewski, T.; Castañer, J.; PNU-140690. Drugs Fut 1998, 23, 2, 146.
2 Romines, K.R.; Bundy, G.L.; Schwartz, T.M.; Tommasi, R.A.; Strohbach, J.W.; Turner, S.R.; Thaisrivongs, S.; Aristoff, P.A.; Johnson, P.D.; Skulnick, H.I.; Skaletzki, L.L.; Anderson, D.J.; Morris, J.; Gammill, R.B.; Luke, G.P. (Pharmacia Corp.); Pyranone cpds. useful to treat retroviral infections. EP 0758327; JP 1997512821; US 5852195; WO 9530670 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 12173 (4S)-4-Phenyl-1,3-oxazolan-2-one; (4S)-4-Phenyl-2-oxazolidinone; (S)-(+)-4-Phenyl-2-oxazolidinone 99395-88-7 C9H9NO2 详情 详情
(II) 17226 (E)-2-pentenoyl chloride C5H7ClO 详情 详情
(III) 17227 (4R)-3-[(E)-2-pentenoyl]-4-phenyl-1,3-oxazolan-2-one C14H15NO3 详情 详情
(IV) 17228 N-(3-methylphenyl)-N,N-bis(trimethylsilyl)amine; trimethyl-N-(3-methylphenyl)-N-(trimethylsilyl)silanamine C13H25NSi2 详情 详情
(V) 17229 (4R)-3-((3S)-3-[3-[bis(trimethylsilyl)amino]phenyl]pentanoyl)-4-phenyl-1,3-oxazolan-2-one C26H38N2O3Si2 详情 详情
(VI) 17230 (4R)-3-[(3S)-3-[3-(dibenzylamino)phenyl]pentanoyl]-4-phenyl-1,3-oxazolidin-2-one C34H34N2O3 详情 详情
(VII) 17231 2-methoxy-2-methyl-1,3-dioxolane; methyl 2-methyl-1,3-dioxolan-2-yl ether C5H10O3 详情 详情
(VIII) 17232 (2S)-2-[(1S)-1-[3-(dibenzylamino)phenyl]propyl]-1-[(4R)-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]-1,3-butanedione C36H36N2O4 详情 详情
(IX) 17233 1-phenyl-3-hexanone C12H16O 详情 详情
(X) 17234 (2S,5R)-2-[(1S)-1-[3-(dibenzylamino)phenyl]propyl]-5-hydroxy-1-[(4R)-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]-5-phenethyl-1,3-octanedione C48H52N2O5 详情 详情
(XI) 17235 (6R)-3-[(1R)-1-[3-(dibenzylamino)phenyl]propyl]-4-hydroxy-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-2-one C39H43NO3 详情 详情
(XII) 17236 (6R)-3-[(1R)-1-(3-aminophenyl)propyl]-4-hydroxy-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-2-one C25H31NO3 详情 详情
(XIII) 17237 5-(trifluoromethyl)-2-pyridinesulfonyl chloride C6H3ClF3NO2S 详情 详情

合成路线2

2) The previously obtained dione (VIII) can also be condensed with 1-phenyl-4-pentyn-1-one (XIV) by means of Ti(OBu)Cl3 in dichloromethane as before yielding the unsaturated hydroxy-dione (XV), which is cyclized by means of potassium tert-butoxide in THF to afford the dihydropyrone (XVI). The hydrogenation of the triple bond of (XVI) with simultaneous debenzylation by means of H2 over Pd/C in methanol/ethyl acetate gives the previously obtained free amine derivative (XII).

1 Graul, J.; Wroblewski, T.; Castañer, J.; PNU-140690. Drugs Fut 1998, 23, 2, 146.
2 Morris, J.K.; Phillips, G.; Judge, T.M.; et al.; Asymmetric syntheses and absolute stereochemistry of 5,6-dihydro-alpha-pyrones, a new class of potent HIV protease inhibitors. J Am Chem Soc 1997, 119, 15, 3627-8.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(VIII) 17232 (2S)-2-[(1S)-1-[3-(dibenzylamino)phenyl]propyl]-1-[(4R)-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]-1,3-butanedione C36H36N2O4 详情 详情
(XII) 17236 (6R)-3-[(1R)-1-(3-aminophenyl)propyl]-4-hydroxy-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-2-one C25H31NO3 详情 详情
(XIV) 17238 1-phenyl-4-hexyn-3-one C12H12O 详情 详情
(XV) 17239 (2S,5R)-2-[(1S)-1-[3-(dibenzylamino)phenyl]propyl]-5-hydroxy-1-[(4R)-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]-5-phenethyl-6-octyne-1,3-dione C48H48N2O5 详情 详情
(XVI) 17240 (6R)-3-[(1R)-1-[3-(dibenzylamino)phenyl]propyl]-4-hydroxy-6-phenethyl-6-(1-propynyl)-5,6-dihydro-2H-pyran-2-one C39H39NO3 详情 详情

合成路线3

1) The condensation of 1-phenylhexan-3-one (I) with ethyl acetate by means of butyllithium and diisopropylamine in THF gives racemic 3-hydroxy-3-(2-phenylethyl)hexanoic acid ethyl ester (II), which is hydrolyzed with NaOH in methanol to the corresponding free acid (III). The optical resolution of (III) with (1R,2S)-(-)-norephedrine (IV) followed by treatment with aqueous HCl yields the chiral (R)-acid (V), which is treated with 4-biphenylyloxymethyl chloride (VI) and diisopropylethylamine in toluene affording the protected ester (VII). The reduction of the ester group of (VII) with diisobutylaluminum hydride (DIBAL) in toluene gives the monoprotected diol (VIII), which is oxidized at the primary hydroxy group with 4-hydroxy-2,2,6,6-tetramethylpiperidinyloxy radical (TEMPO) and NaOCl yielding the corresponding aldehyde (IX). The condensation of (IX) with (R)-3-(3-nitrophenyl)pentanoic acid methyl ester (X) by means of sodium hexamethyldisilazide (NaHMDS) in THF gives the hydroxyester (XI) as a mixture of four diastereomers. This mixture is oxidized with pyridinium chlorochromate (PCC) in dichloromethane to afford the ketoester (XII) also as a mixture of two diastereomers. Elimination of the biphenylyloxymethyl protecting group with H2SO4 in methanol yields the hydroxy ketoester (XIII).

1 Fors, K.S.; et al.; A convergent, scalable synthesis of HIV protease inhibitor PNU-140690. J Org Chem 1998, 63, 21, 7348.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
17491 ethyl acetate 141-78-6 C4H8O2 详情 详情
(I) 17233 1-phenyl-3-hexanone C12H16O 详情 详情
(II) 21156 ethyl 3-hydroxy-3-phenethylhexanoate C16H24O3 详情 详情
(III) 21157 3-hydroxy-3-phenethylhexanoic acid C14H20O3 详情 详情
(IV) 13355 2-Amino-1-phenyl-1-propanol; (1S,2R)-(+)-Norephedrine 37577-28-9 C9H13NO 详情 详情
(IV) 21158 (1R,2S)-2-amino-1-phenyl-1-propanol C9H13NO 详情 详情
(V) 21159 (3R)-3-hydroxy-3-phenethylhexanoic acid C14H20O3 详情 详情
(VI) 21160 [1,1'-biphenyl]-4-yl chloromethyl ether; 4-(chloromethoxy)-1,1'-biphenyl C13H11ClO 详情 详情
(VII) 21161 ([1,1'-biphenyl]-4-yloxy)methyl (3R)-3-[([1,1'-biphenyl]-4-yloxy)methoxy]-3-phenethylhexanoate C40H40O5 详情 详情
(VIII) 21162 (3R)-3-[([1,1'-biphenyl]-4-yloxy)methoxy]-3-phenethyl-1-hexanol C27H32O3 详情 详情
(IX) 21163 (3R)-3-[([1,1'-biphenyl]-4-yloxy)methoxy]-3-phenethylhexanal C27H30O3 详情 详情
(X) 21164 methyl (3S)-3-(3-nitrophenyl)pentanoate C12H15NO4 详情 详情
(XI) 21165 methyl (5R)-5-[([1,1'-biphenyl]-4-yloxy)methoxy]-3-hydroxy-2-[(1S)-1-(3-nitrophenyl)propyl]-5-phenethyloctanoate C39H45NO7 详情 详情
(XII) 21166 methyl (5R)-5-[([1,1'-biphenyl]-4-yloxy)methoxy]-2-[(1S)-1-(3-nitrophenyl)propyl]-3-oxo-5-phenethyloctanoate C39H43NO7 详情 详情
(XIII) 21167 methyl (5R)-5-hydroxy-2-[(1S)-1-(3-nitrophenyl)propyl]-3-oxo-5-phenethyloctanoate C26H33NO6 详情 详情

合成路线4

The hydroxy ketoester (XIII) (Scheme 24009402a), which is cyclized by means of NaOH in methanol/water affording the dihydropyranone (XIV). The reduction of the nitro group of (XIV) with hydrogen over Pd/C in THF gives the corresponding aniline (XV), which is finally amidated with 5-(trifluoromethyl)pyridine-2-sulfonyl chloride and pyridine in DMSO.

1 Fors, K.S.; et al.; A convergent, scalable synthesis of HIV protease inhibitor PNU-140690. J Org Chem 1998, 63, 21, 7348.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(XIII) 21167 methyl (5R)-5-hydroxy-2-[(1S)-1-(3-nitrophenyl)propyl]-3-oxo-5-phenethyloctanoate C26H33NO6 详情 详情
(XIV) 21168 (6R)-4-hydroxy-3-[(1R)-1-(3-nitrophenyl)propyl]-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-2-one C25H29NO5 详情 详情
(XV) 17236 (6R)-3-[(1R)-1-(3-aminophenyl)propyl]-4-hydroxy-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-2-one C25H31NO3 详情 详情
(XVI) 17237 5-(trifluoromethyl)-2-pyridinesulfonyl chloride C6H3ClF3NO2S 详情 详情

合成路线5

2) The chiral intermediate (X) has been obtained by two different ways: a) The Knovenagel condensation of dimethyl malonate (XVII) with 3-nitrobenzaldehyde (XVIII) gives the corresponding benzylidenemalonate (XIX), which is alkylated with diethyl zinc and CuBr in DMSO yielding 2-[1-(3-nitrophenyl)propyl]malonic acid dimethyl ester (XX). The partial decarboxylation of (XX) with 6N HCl affords racemic 3-(3-nitrophenyl)pentanoic acid (XXI), which is esterified with methanol/HCl to the racemic methyl ester (XXII). Finally, this racemate is resolved by chromatography over a chiral (R,R)Whelk-O1 column giving the desired intermediate (X). b) The regioselective acetylation of 1-(3-nitrophenyl)-1-propanol (XXIII) with isopropenyl acetate (XXIV) catalyzed by Amano P30 lipase gives a mixture of the (S)-acetate (XXV) and unreacted (R)-alcohol (XXVI). After separation, (XXVI) was mesylated with mesyl chloride as usual yielding mesylate (XXVII), which was condensed with the sodium salt of diethyl malonate (XXVIII) affording the chiral malonic ester (XXIX). Partial decarboxylation of (XXIX) with 6N HCl gives the chiral pentanoic acid (XXX), which is finally esterified to the desired intermediate (X) with methanol/HCl.

1 Fors, K.S.; et al.; A convergent, scalable synthesis of HIV protease inhibitor PNU-140690. J Org Chem 1998, 63, 21, 7348.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(X) 21164 methyl (3S)-3-(3-nitrophenyl)pentanoate C12H15NO4 详情 详情
(XVII) 19373 dimethyl malonate;Methyl malonate;Propanedioic acid dimethyl ester 108-59-8 C5H8O4 详情 详情
(XVIII) 12646 3-Nitrobenzaldehyde 99-61-6 C7H5NO3 详情 详情
(XIX) 21173 dimethyl 2-(3-nitrobenzylidene)malonate C12H11NO6 详情 详情
(XX) 21174 dimethyl 2-[1-(3-nitrophenyl)propyl]malonate C14H17NO6 详情 详情
(XXI) 21175 3-(3-nitrophenyl)pentanoic acid C11H13NO4 详情 详情
(XXII) 21176 methyl 3-(3-nitrophenyl)pentanoate C12H15NO4 详情 详情
(XXIII) 21177 1-(3-nitrophenyl)-1-propanol C9H11NO3 详情 详情
(XXIV) 21178 isopropenyl acetate 108-22-5 C5H8O2 详情 详情
(XXV) 21179 (1S)-1-(3-nitrophenyl)propyl acetate C11H13NO4 详情 详情
(XXVI) 21180 (1R)-1-(3-nitrophenyl)-1-propanol C9H11NO3 详情 详情
(XXVII) 21181 (1R)-1-(3-nitrophenyl)propyl methanesulfonate C10H13NO5S 详情 详情
(XXVIII) 21182 Diethyl malonate sodium salt C7H11NaO4 详情 详情
(XXIX) 21183 diethyl 2-[(1S)-1-(3-nitrophenyl)propyl]malonate C16H21NO6 详情 详情
(XXX) 21184 (3S)-3-(3-nitrophenyl)pentanoic acid C11H13NO4 详情 详情

合成路线6

A new synthesis of PNU-140690 has been developed: The condensation of 1-phenyl-3-hexanone (I) with methyl acetoacetate (II) by means of NaH in THF, followed by cyclization gives the hydroxypyrone (III), which by condensation with 3-nitrobenzaldehyde (IV) by means of AlCl3 in THF yields the benzylidene-pyrone (V). The alkylation of (V) with Et3Al, CuBr-Me2S in THF affords intermediate (VI), which is reduced at the nitro group with H2 over Pd/C in methanol giving the racemic amine (VII). The optical resolution of the N-benzyloxycarbonyl derivative of (VII) with chiral HPLC yielded the desired (R,R)-enantiomer (VIII), which was finally sulfonated with 5-(trifluoromethyl)pyridine-2-sulfonyl chloride (IX) in pyridine/dichloromethane.

1 Turner, S.R.; Strohbach, J.W.; Tommasi, R.A.; Aristoff, P.A.; Johnson, P.D.; Skulnick, H.I.; Dolak, L.A.; Seest, E.P.; Tomich, P.K.; Bohanon, M.J.; Horng, M.M.; Lynn, J.C.; Chong, K.T.; Hinshaw, R.R.; Watenpaugh, K.D.; Janakiraman, M.N.; Thaisrivongs, S.; Tipranavir (PNU-140690): A potent, orally bioavailable nonpeptidic HIV protease inhibitor of the 5,6-dihydro-4-hydroxy-2-pyrone sulfonamide class. J Med Chem 1998, 41, 18, 3467.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 17233 1-phenyl-3-hexanone C12H16O 详情 详情
(II) 11791 methyl 3-oxobutanoate; Methyl acetoacetate 105-45-3 C5H8O3 详情 详情
(III) 32879 4-hydroxy-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-2-one C16H20O3 详情 详情
(IV) 12646 3-Nitrobenzaldehyde 99-61-6 C7H5NO3 详情 详情
(V) 32880 3-[(Z)-(3-nitrophenyl)methylidene]-6-phenethyl-6-propyldihydro-2H-pyran-2,4-dione C23H23NO5 详情 详情
(VI) 32881 4-hydroxy-3-[1-(3-nitrophenyl)propyl]-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-2-one C25H29NO5 详情 详情
(VII) 32882 3-[1-(3-aminophenyl)propyl]-4-hydroxy-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-2-one C25H31NO3 详情 详情
(VIII) 17236 (6R)-3-[(1R)-1-(3-aminophenyl)propyl]-4-hydroxy-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-2-one C25H31NO3 详情 详情
(IX) 17237 5-(trifluoromethyl)-2-pyridinesulfonyl chloride C6H3ClF3NO2S 详情 详情

合成路线7

 

1 Wilken J. Nerenz F, Kanschik-Conndsen A. 2004. A process for the synthesis of 3-hydroxy3-(2-phenylethyl) hexanoic acid,useful as an intermediate for antiviral. US 2004110957(本专利属于Honey-well International, Inc.,USA)
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(V) 21159 (3R)-3-hydroxy-3-phenethylhexanoic acid C14H20O3 详情 详情
(VII) 66860 (S)-4-hydroxy-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-2-one   C16H20O3 详情 详情
(I) 17233 1-phenyl-3-hexanone C12H16O 详情 详情
(II) 16640 Ethyl 2-bromoacetate; Ethyl bromoacetate 105-36-2 C4H7BrO2 详情 详情
(III) 21156 ethyl 3-hydroxy-3-phenethylhexanoate C16H24O3 详情 详情
(IV) 13355 2-Amino-1-phenyl-1-propanol; (1S,2R)-(+)-Norephedrine 37577-28-9 C9H13NO 详情 详情
(VI) 66856 (S)-ethyl 5-hydroxy-3-oxo-5-phenethyloctanoate   C18H26O4 详情 详情
(IX) 17236 (6R)-3-[(1R)-1-(3-aminophenyl)propyl]-4-hydroxy-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-2-one C25H31NO3 详情 详情

合成路线8

 

1 Trost BM, Andersen NG. 2002. Utilization of molybdenum-and palladium-catalyzed dynamic kinetic asymmetric transformations for the preparation of tertiary and quatemary stereogenic centers; a concise synthesis of tipranavir. J Am Chem Soc, 124 (48): 14320~14321
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(IV) 66865 methyl 3-(3-nitrophenyl)pent-4-enoate   C12H13NO4 详情 详情
(V) 16524 bromo(vinyl)magnesium 1826-67-1 C2H3BrMg 详情 详情
(VII) 66867 1-propyl-1-vinylcyclopropane   C8H14 详情 详情
(IX) 66869 (E)-2-((4-methoxybenzyl)oxy)-2-styrylpentan-1-ol   C21H26O3 详情 详情
(XII) 66872 (5S)-methyl 5-((4-methoxybenzyl)oxy)-2-((R)-1-(3-nitrophenyl)allyl)-3-oxo-5-phenethyloctanoate   C34H39NO7 详情 详情
(XIII) 66873 (5S)-methyl 5-hydroxy-2-((R)-1-(3-nitrophenyl)allyl)-3-oxo-5-phenethyloctanoate   C26H31NO6 详情 详情
(XIV) 66874 (S)-4-hydroxy-3-((R)-1-(3-nitrophenyl)allyl)-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-2-one   C25H27NO5 详情 详情
(XV) 21168 (6R)-4-hydroxy-3-[(1R)-1-(3-nitrophenyl)propyl]-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-2-one C25H29NO5 详情 详情
(I) 66862 1-(3-nitrophenyl)prop-2-en-1-ol   C9H9NO3 详情 详情
(II) 66863 tert-butyl (1-(3-nitrophenyl)allyl) carbonate   C14H17NO5 详情 详情
(III) 66864 dimethyl 2-(1-(3-nitrophenyl)allyl)malonate   C14H15NO6 详情 详情
(VI) 66866 1-chloropentan-2-one   C5H9ClO 详情 详情
(VIII) 66868 2-((4-methoxybenzyl)oxy)-2-vinylpentan-1-ol   C15H22O3 详情 详情
(X) 66870 2-((4-methoxybenzyl)oxy)-2-phenethylpentan-1-ol   C21H28O3 详情 详情
(XI) 66871 1-methoxy-4-(((3-phenethylhex-1-en-3-yl)oxy)methyl)benzene   C22H28O2 详情 详情
(XVI) 66879 2-((4-methoxybenzyl)oxy)-2-phenethylpentanal   C21H26O3 详情 详情

合成路线9

 

1 Judge TM, Phillips G, Moms JK, et aL. 1997. A symmetric syntheses and absolute stereochemistry of 5,6-dihydro-α-pyrones, a new class of potent HIV proteese inhibitors. J Am Chem Soc, 119 (15): 3627~3628
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 12173 (4S)-4-Phenyl-1,3-oxazolan-2-one; (4S)-4-Phenyl-2-oxazolidinone; (S)-(+)-4-Phenyl-2-oxazolidinone 99395-88-7 C9H9NO2 详情 详情
(II) 17227 (4R)-3-[(E)-2-pentenoyl]-4-phenyl-1,3-oxazolan-2-one C14H15NO3 详情 详情
(III) 17228 N-(3-methylphenyl)-N,N-bis(trimethylsilyl)amine; trimethyl-N-(3-methylphenyl)-N-(trimethylsilyl)silanamine C13H25NSi2 详情 详情
(V) 17231 2-methoxy-2-methyl-1,3-dioxolane; methyl 2-methyl-1,3-dioxolan-2-yl ether C5H10O3 详情 详情
(VI) 17232 (2S)-2-[(1S)-1-[3-(dibenzylamino)phenyl]propyl]-1-[(4R)-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]-1,3-butanedione C36H36N2O4 详情 详情
(XI) 66877 2-(1-(3-(dibenzylamino)phenyl)propyl)-5-hydroxy-1-(2-oxo-4-phenyloxazolidin-3-yl)-5-phenethyloctane-1,3-dione   C48H52N2O5 详情 详情
(IV) 17229 (4R)-3-((3S)-3-[3-[bis(trimethylsilyl)amino]phenyl]pentanoyl)-4-phenyl-1,3-oxazolan-2-one C26H38N2O3Si2 详情 详情
(VII) 10385 4-Heptanone; Dipropyl ketone 123-19-3 C7H14O 详情 详情
(VIII) 17233 1-phenyl-3-hexanone C12H16O 详情 详情
(IX) 66878 2-(1-(3-(dibenzylamino)phenyl)propyl)-5-hydroxy-1-(2-oxo-4-phenyloxazolidin-3-yl)-5-propyloctane-1,3-dione   C43H50N2O5 详情 详情
(X) 17234 (2S,5R)-2-[(1S)-1-[3-(dibenzylamino)phenyl]propyl]-5-hydroxy-1-[(4R)-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]-5-phenethyl-1,3-octanedione C48H52N2O5 详情 详情
(XII) 66875 3-(1-(3-(dibenzylamino)phenyl)propyl)-4-hydroxy-6,6-dipropyl-5,6-dihydro-2H-pyran-2-one   C34H41NO3 详情 详情
(XIII) 17235 (6R)-3-[(1R)-1-[3-(dibenzylamino)phenyl]propyl]-4-hydroxy-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-2-one C39H43NO3 详情 详情
(XIV) 66876 N-(3-(1-(4-hydroxy-2-oxo-6,6-dipropyl-5,6-dihydro-2H-pyran-3-yl)propyl)phenyl)-5-(trifluoromethyl)pyridine-2-sulfonamide   C26H31F3N2O5S 详情 详情
(XVI) 17238 1-phenyl-4-hexyn-3-one C12H12O 详情 详情
(XVII) 17239 (2S,5R)-2-[(1S)-1-[3-(dibenzylamino)phenyl]propyl]-5-hydroxy-1-[(4R)-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]-5-phenethyl-6-octyne-1,3-dione C48H48N2O5 详情 详情
(XVIII) 17240 (6R)-3-[(1R)-1-[3-(dibenzylamino)phenyl]propyl]-4-hydroxy-6-phenethyl-6-(1-propynyl)-5,6-dihydro-2H-pyran-2-one C39H39NO3 详情 详情
(XIX) 17236 (6R)-3-[(1R)-1-(3-aminophenyl)propyl]-4-hydroxy-6-phenethyl-6-propyl-5,6-dihydro-2H-pyran-2-one C25H31NO3 详情 详情
Extended Information